cal. The Company's proprietary LNP Delivery Platform makes possible the successful delivery and enablement of RNAi as well as mRNA drugs. Tekmira's Lipid Nanoparticle (LNP) technology represents the most widely adopted RNAi delivery technology to date, as it allows drugs to be encapsulated in tiny particles made